|
|
楼主 |
发表于 18-11-2021 07:55 AM
|
显示全部楼层
Notice of Person Ceasing (Section 139 of CA 2016)| MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD |
Particulars of Substantial Securities HolderName | I CONCEPT GLOBAL GROWTH FUND | Address | 89, Nexus Way, Camana Bay,Grand Cayman,
KY1-9009, Cayman Islands
Cayman Islands. | Company No. | BS-328056 | Nationality/Country of incorporation | Cayman Islands | Descriptions (Class) | Ordinary Shares | Name of registered holder | Affin Hwang Nominees (Asing) Sdn Bhd Exempt an for Phillip Securities (Hong Kong) Ltd(for I Concept) | Address of registered holder | 27th Floor, MenaraBoustead, 69 JalanRaja Chulan,50200 KualaLumpur, Malaysia. | Date of cessation | 02 Nov 2021 |
No of securities disposed | 4,688,000 | Circumstances by reason of which a person ceases to be a substantial shareholder | Disposal of 2,088,000 shares and 2,600,000 shares on 1 November 2021 and 2 November 2021 respectively via open market and ceased to be a Substantial Shareholder of the Company. | Nature of interest | Direct Interest |  | Date of notice | 03 Nov 2021 | Date notice received by Listed Issuer | 03 Nov 2021 |
|
|
|
|
|
|
|
|
|
|
|
|
楼主 |
发表于 18-11-2021 07:56 AM
|
显示全部楼层
Notice of Interest Sub. S-hldr (Section 137 of CA 2016)| MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD |
Particulars of Substantial Securities HolderName | PIXELVEST SDN BHD | Address | Emporis Soho, F-16-03, Block F,
Emporis Persiaran Surian Seksyen 3,
Kota Damansara, Taman Sains Selangor,
Petaling Jaya
47810 Selangor
Malaysia. | Company No. | 202001018665 (1374985-D) | Nationality/Country of incorporation | Malaysia | Descriptions (Class) | Ordinary Shares | Name of registered holder | PIXELVEST SDN BHD | Address of registered holder | Emporis Soho, F-16-03, Block F, Emporis Persiaran Surian Seksyen 3, Kota Damansara, Taman Sains Selangor, 47810 Petaling Jaya, Selangor, Malaysia. |
| Date interest acquired & no of securities acquired | Date interest acquired | 01 Nov 2021 | No of securities | 550,000 | Circumstances by reason of which Securities Holder has interest | Acquisition of 550,000 shares in the open market and becoming a substantial shareholder of the Company. | Nature of interest | Direct Interest | | | Total no of securities after change | Direct (units) | 6,680,000 | Direct (%) | 5.378 | Indirect/deemed interest (units) | 0 | Indirect/deemed interest (%) | 0 | Date of notice | 03 Nov 2021 | Date notice received by Listed Issuer | 03 Nov 2021 |
|
|
|
|
|
|
|
|
|
|
|
|
楼主 |
发表于 13-2-2022 10:39 AM
|
显示全部楼层
SUMMARY OF KEY FINANCIAL INFORMATION
30 Sep 2021 |
| | INDIVIDUAL PERIOD | CUMULATIVE PERIOD | CURRENT YEAR QUARTER | PRECEDING YEAR
CORRESPONDING
QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR
CORRESPONDING
PERIOD | 30 Sep 2021 | 30 Sep 2020 | 30 Sep 2021 | 30 Sep 2020 | $$'000 | $$'000 | $$'000 | $$'000 |
| 1 | Revenue | 9,316 | 87 | 9,316 | 87 | | 2 | Profit/(loss) before tax | 239 | -833 | 239 | -833 | | 3 | Profit/(loss) for the period | 239 | -833 | 239 | -833 | | 4 | Profit/(loss) attributable to ordinary equity holders of the parent | 239 | -833 | 239 | -833 | | 5 | Basic earnings/(loss) per share (Subunit) | 0.20 | -0.80 | 0.20 | -0.80 | | 6 | Proposed/Declared dividend per share (Subunit) | 0.00 | 0.00 | 0.00 | 0.00 |
|
| AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | 7
| Net assets per share attributable to ordinary equity holders of the parent ($$) | 0.2421 | 0.1513
|
|
|
|
|
|
|
|
|
|
|
|
|
楼主 |
发表于 13-2-2022 10:41 AM
|
显示全部楼层
| MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD |
Date of change | 30 Nov 2021 | Name | TAN SRI DATUK (DR) RAFIAH BINTI SALIM | Age | 74 | Gender | Female | Nationality | Malaysia | Designation | Chairman | Directorate | Independent and Non Executive | Type of change | Retirement |
QualificationsNo | Qualifications | Major/Field of Study | Institute/University | Additional Information |
Working experience and occupation | | Family relationship with any director and/or major shareholder of the listed issuer | NIL | Any conflict of interests that he/she has with the listed issuer | NIL | Details of any interest in the securities of the listed issuer or its subsidiaries | Direct : 200,000 Ordinary Shares |
|
|
|
|
|
|
|
|
|
|
|
|
楼主 |
发表于 14-2-2022 10:17 AM
|
显示全部楼层
| MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD |
Date of change | 30 Nov 2021 | Name | MR CHEAH SEK HON | Age | 46 | Gender | Male | Nationality | Malaysia | Type of change | Resignation | Designation | Chief Financial Officer | Reason | Pursue other career opportunities |
Date of change | 30 Nov 2021 | Name | MISS TEOH AI LING | Age | 38 | Gender | Female | Nationality | Malaysia | Type of change | Appointment | Designation | Others |
Qualifications| No | Qualifications | Major/Field of Study | Institute/University | Additional Information | | 1 | Professional Qualification | Accounting | Fellow Member of The Association of Chartered Certified Accountants | 2014 | | 2 | Professional Qualification | Accounting | Member of The Association of Chartered Certified Accountants | 2009 | | 3 | Professional Qualification | Accounting | The Association of Chartered Certified Accountants | 2005 - 2007 | | 4 | Others | Commerce Financial Reporting (Advanced Diploma) | Tunku Abdul Rahman College | 2003 - 2005 |
| | | Working experience and occupation | Ms Teoh Ai Ling (Ms Teoh) has 15 years of work experience in the finance and accounting fields. The details of her work experience are as follow:-1. Served as Financial Controller in public listed companies;2. Was responsible for financial reporting to comply with MFRS, such as preparing quarterly reports to Bursa, reporting to the Board of Directors;3. Ensured compliance of all legal requirements, such as general accounting principles/standards/Bursa listing requirements, Income Tax Act, etc.;4. Liaised with auditors, bankers, tax agents and other relevant external business partners, and ensured tax computations for the Company; and5. Reviewed financial work policies, processes and procedures to comply with the companys objectives. Monitored daily cash flow for operations requirements of the company and recommended necessary actions to the management. |
|
|
|
|
|
|
|
|
|
|
|
|
楼主 |
发表于 22-9-2022 08:50 AM
|
显示全部楼层
|
|
|
|
|
|
|
|
|
|
|
楼主 |
发表于 24-9-2022 09:20 AM
|
显示全部楼层
|
|
|
|
|
|
|
|
|
|
|
楼主 |
发表于 24-9-2022 09:20 AM
|
显示全部楼层
|
|
|
|
|
|
|
|
|
|
|
楼主 |
发表于 24-9-2022 09:21 AM
|
显示全部楼层
|
|
|
|
|
|
|
|
|
|
|
楼主 |
发表于 24-9-2022 09:21 AM
|
显示全部楼层
|
|
|
|
|
|
|
|
|
|
|
楼主 |
发表于 13-10-2022 09:27 AM
|
显示全部楼层
|
|
|
|
|
|
|
|
|
|
|
楼主 |
发表于 8-9-2023 12:53 PM
|
显示全部楼层
|
|
|
|
|
|
|
|
|
|
|
楼主 |
发表于 12-9-2023 09:43 AM
|
显示全部楼层
|
|
|
|
|
|
|
|
|
|
|
楼主 |
发表于 14-9-2023 05:49 AM
|
显示全部楼层
本帖最后由 icy97 于 5-3-2024 05:08 PM 编辑
| MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD |
Date of change | 04 Mar 2024 | Name | ENCIK MUHAMMAD BADRI BIN HUSSIN | Age | 50 | Gender | Male | Nationality | Malaysia | Type of change | Redesignation | Previous Position | Director | New Position | Chief Operating Officer | Directorate | Independent and Non Executive |
QualificationsNo | Qualifications | Major/Field of Study | Institute/University | Additional Information | | 1 | Masters | Business Administration | Universiti Malaysia Pahang | | | 2 | Degree | Bachelor of Accounting (Hons) | Universiti Utara Malaysia | |
Working experience and occupation | Encik Muhammad Badri Bin Hussin ("Encik Badri") was the Group CEO of a private entity, Integra Healthcare Technology Sdn Bhd since 1st February 2023. He graduated from Universiti Utara Malaysia (UUM) in 1996 with Bachelor in Accountancy (Hons) and subsequently obtained a Master of Business Administration (MBA) from Universiti Malaysia Pahang (UMP) in 2015. Encik Badri began his career as an auditor with PricewaterhouseCoopers for four years from 1997 to 2001. He subsequently joined a retail pharmaceutical company, PharmaCare Medicine Shoppe Sdn Bhd in 2001. He later joined KPJ Healthcare Group and served with KPJ Healthcare Berhad for twenty-one years. He started as an accountant at KPJ Ampang Puteri in 2002 and was subsequently appointed as General Manager for Hospital Penawar Pasir Gudang in 2004 and Puteri Specialist Hospital Johor Baharu in 2006. He was then assigned to be a Director to manage two hospitals in Indonesia namely Rumah Sakit Medika Permata Hijau Jakarta in 2006 and Rumah Sakit Medika Bumi Serpong Damai Tangerang in 2009. In 2012, he was appointed as a General Manager of former KPJ Kuantan Specialist Hospital and subsequently promoted as Chief Executive Officer. He was involved in the development, commissioning and opening of the new KPJ Pahang Specialist Hospital in 2016 and was appointed as its Chief Executive Officer. In 2017, he was appointed as Chief Executive Officer of KPJ Tawakkal KL. In 2020, he was appointed as Chief Executive Officer as well as Director of KPJ Ampang Puteri Specialist Hospital. |
|
|
|
|
|
|
|
|
|
|
|
|
楼主 |
发表于 5-3-2024 04:39 PM
|
显示全部楼层
本帖最后由 icy97 于 8-3-2024 02:16 AM 编辑
| MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD |
Date of change | 04 Mar 2024 | Name | ENCIK MUHAMMAD BADRI BIN HUSSIN | Age | 50 | Gender | Male | Nationality | Malaysia | Type of change | Redesignation | Previous Position | Director | New Position | Chief Operating Officer | Directorate | Executive |
QualificationsNo | Qualifications | Major/Field of Study | Institute/University | Additional Information | | 1 | Masters | Business Administration | Universiti Malaysia Pahang | | | 2 | Degree | Bachelor of Accounting (Hons) | Universiti Utara Malaysia | |
Working experience and occupation | Encik Muhammad Badri Bin Hussin ("Encik Badri") was the Group CEO of a private entity, Integra Healthcare Technology Sdn Bhd since 1st February 2023. He graduated from Universiti Utara Malaysia (UUM) in 1996 with Bachelor in Accountancy (Hons) and subsequently obtained a Master of Business Administration (MBA) from Universiti Malaysia Pahang (UMP) in 2015. Encik Badri began his career as an auditor with PricewaterhouseCoopers for four years from 1997 to 2001. He subsequently joined a retail pharmaceutical company, PharmaCare Medicine Shoppe Sdn Bhd in 2001. He later joined KPJ Healthcare Group and served with KPJ Healthcare Berhad for twenty-one years. He started as an accountant at KPJ Ampang Puteri in 2002 and was subsequently appointed as General Manager for Hospital Penawar Pasir Gudang in 2004 and Puteri Specialist Hospital Johor Baharu in 2006. He was then assigned to be a Director to manage two hospitals in Indonesia namely Rumah Sakit Medika Permata Hijau Jakarta in 2006 and Rumah Sakit Medika Bumi Serpong Damai Tangerang in 2009. In 2012, he was appointed as a General Manager of former KPJ Kuantan Specialist Hospital and subsequently promoted as Chief Executive Officer. He was involved in the development, commissioning and opening of the new KPJ Pahang Specialist Hospital in 2016 and was appointed as its Chief Executive Officer. In 2017, he was appointed as Chief Executive Officer of KPJ Tawakkal KL. In 2020, he was appointed as Chief Executive Officer as well as Director of KPJ Ampang Puteri Specialist Hospital. |
|
|
|
|
|
|
|
|
|
|
|
|
楼主 |
发表于 14-3-2024 12:13 AM
|
显示全部楼层
|
|
|
|
|
|
|
|
|
|
|
楼主 |
发表于 14-3-2024 08:41 PM
|
显示全部楼层
Type | Announcement | Subject | OTHERS | Description | MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD ("MGRC" OR "COMPANY") - COLLABORATION AGREEMENT BETWEEN MGRC THERAPEUTICS SDN BHD AND UNIVERSITI SAINS MALAYSIA | Further to the Company's announcement dated 13 March 2024 on the collaboration agreement entered into between MGRC Therapeutics Sdn Bhd, a wholly owned subsidiary of the Company, and Universiti Sains Malaysia, the Board of Directors of MGRC would like to announce that the estimated funds to be provided from internally generated funds of the Group for the Project are as follows: - Budget administrative for research materials and supplies and professional services for exploring the genetics of Penang Woman is RM50,000.00.
- Budget administrative for research materials and supplies used in determining the age of the ancient Penang Woman Skeleton using the Accelerator Mass Spectrometry (“AMS”) dating technique is RM3,000.00.
This announcement is dated 14 March 2024. |
|
|
|
|
|
|
|
|
|
|
|
|
楼主 |
发表于 19-4-2024 01:24 AM
|
显示全部楼层
|
|
|
|
|
|
|
|
|
| |
 本周最热论坛帖子
|
2220 
46
